Multi-strain probiotic therapy shows promise in preventing bacterial vaginosis recurrence

A global team of experts has identified a promising new approach to prevent recurrence of bacterial vaginosis (BV), a condition that affects millions of women worldwide. In a Phase I randomized clinical trial of women in the U.S. and South Africa, researchers found that a short course of a multi-strain probiotic restored protective bacteria to the vagina, significantly reducing disease recurrence.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup